Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Dual antiplatelet therapy (DAPT) has become a mainstay in the secondary prevention of cardiovascular (CV) events in patients with a recent history of myocardial infarction (MI) or recent percutaneous...
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
The practice of therapeutic injections of corticosteroids has been a longstanding procedure to relieve pain and improve functioning in patients with knee osteoarthritis.
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
LH is a 60-year-old white male with a 10-year history of longstanding hypertension as well as systolic heart failure (sys-HF) with a reduced ejection fraction (EF) of 20%.
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
Last month we reviewed the case of CD, a 63-year-old white female who was diagnosed with chronic obstructive pulmonary disease (COPD) and initiated on tiotropium.
Eric A. Dietrich, PharmD, BCPS; Kyle Davis, PharmD, BCPS
While its pharmacokinetics suggest that apixaban is adequate for use in patients on hemodialysis, is there clear evidence showing that the agent is both safe and effective in this role?
Eric A. Dietrich, PharmD, BCPS; Louis Kuritzky, MD
As with the decision to initiate or continue warfarin therapy, decisions surrounding bridge therapy are patient-specific and should be evaluated on a case-by-case basis.
